This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Sunitinib Malate in Patients With Non-Clear Cell R...
Clinical trial

Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer

Read time: 1 mins
Last updated:20th Apr 2007

To determine the clinical activity of SUTENT® (sunitinib malate) in non-clear cell renal cell cancer (RCC). Clinical activity will take into account response rate and progression free survival (PFS).

Category Value
Study start date 2007-04-20

View full details